An FDA approval boosted the pharma stock.
News & Analysis: Endo International
Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.
ENDP earnings call for the period ending March 31, 2020.
The drugmaker easily beat revenue and earnings estimates with a big jump in sterile injectables sales.
A billion-dollar market opportunity exists for an opioid manufacturer plagued with lawsuits, but will it be enough for a comeback?
ENDP earnings call for the period ending December 31, 2019.
These stocks skyrocketed during healthcare's biggest event of the year -- the J.P. Morgan Healthcare Conference.
ENDP earnings call for the period ending September 30, 2019.
Investors are excited about the potential for a settlement in opioid litigation.
It looks like a short-squeeze scenario is unfolding.